Circio Holding is trading at NOK 12.70, down 10.31% now; no clear company-specific catalyst has been identified.
- No company-specific announcement dated August 27 or August 28, 2026 was identified.
- Circio’s latest listed release, dated August 26, concerned joint in-vivo cell-therapy research with Full Circles Therapeutics and contained no stated negative catalyst.
- Modest broader-market weakness does not clearly explain the decline.